| Literature DB >> 32651598 |
Vera D Jäger1,2,3, Robin Lamm2,4, Kira Küsters5,6, Gizem Ölçücü1,5, Marco Oldiges5,6, Karl-Erich Jaeger1,2,5, Jochen Büchs2,4, Ulrich Krauss7,8,9.
Abstract
Bacterial inclusion bodies (IBs) have long been considered as inactive, unfolded waste material produced by heterologous overexpression of recombinant genes. In industrial applications, they are occasionally used as an alternative in cases where a protein cannot be expressed in soluble form and in high enough amounts. Then, however, refolding approaches are needed to transform inactive IBs into active soluble protein. While anecdotal reports about IBs themselves showing catalytic functionality/activity (CatIB) are found throughout literature, only recently, the use of protein engineering methods has facilitated the on-demand production of CatIBs. CatIB formation is induced usually by fusing short peptide tags or aggregation-inducing protein domains to a target protein. The resulting proteinaceous particles formed by heterologous expression of the respective genes can be regarded as a biologically produced bionanomaterial or, if enzymes are used as target protein, carrier-free enzyme immobilizates. In the present contribution, we review general concepts important for CatIB production, processing, and application. KEY POINTS: • Catalytically active inclusion bodies (CatIBs) are promising bionanomaterials. • Potential applications in biocatalysis, synthetic chemistry, and biotechnology. • CatIB formation represents a generic approach for enzyme immobilization. • CatIB formation efficiency depends on construct design and expression conditions.Entities:
Keywords: Biocatalysis; Catalytically active inclusion bodies; Enzyme immobilization; Protein co-localization; Protein engineering; Synthetic biology; Synthetic reaction cascades; Upstream and downstream processing
Mesh:
Substances:
Year: 2020 PMID: 32651598 PMCID: PMC7413871 DOI: 10.1007/s00253-020-10760-3
Source DB: PubMed Journal: Appl Microbiol Biotechnol ISSN: 0175-7598 Impact factor: 4.813
Fig. 1(Cat)IB formation in bacteria. a Cellular processes leading to the formation of inclusion bodies (IBs), which are subsequently b deposited at the cell poles likely driven by nucleoid exclusion (Rinas et al. 2017; Kopito 2000). Structural regions that adopt a native or native-like fold are shown as red-filled circles. Aggregation-prone sequence stretches are depicted as blue-filled circles. c Fusion protein architectures for the induction of CatIB formation. In all cases, an aggregation-inducing CatIB-tag is fused either N- or C-terminally to a protein of interest (POI). To link both protein modules, usually linker polypeptides (L) of variable length are used. d Overlay of phase-contrast and fluorescence microscopy image of TDoT-L-YFP producing E. coli BL21(DE3) cells (Jäger et al. 2019a). The lower right panel depicts a close-up view to better visualize polar localization of the produced CatIBs. The upper right panel depicts a scanning electron microscopy image of isolated CatIB particles
Overview of different IB-inducing elements. Cases where residual activity was compared only to cell lysate are marked with *. 1CatIB formation efficiency: defined as the activity, or in case of fluorescent proteins, fluorescence, of the insoluble IBs relative to the activity/fluorescence of the crude cell extract. 2Residual activity compared to purified enzyme. 3MenD: 2-succinyl-5-enol-pyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase. 4Residual-specific fluorescence compared to cell lysate. 5GalU: UDP-glucose pyrophosphorylase. 6Volumetric activity. n.i. no information provided. n.a. not applicable
| Name (origin) | ||||||||
| I. Artificial peptides | ||||||||
| L6KD | 8 | Amphophilic | PTPPTT PTPPTTPTPTP Unstructured | Lipase A | 80 | 30* | Zhou et al. ( | |
| Amadoriase II | 61 | 93* | Zhou et al. ( | |||||
| β-xylosidase | 84 | 26* | Zhou et al. ( | |||||
| GFP | n.i. | n.a. | Zhou et al. ( | |||||
| GFIL8 | 8 | β-sheet | PTPPTT PTPPTTPTPTP Unstructured | Lipase A | 89 | 43* | Wang et al. ( | |
| Amadoriase II | 93 | 54* | Wang et al. ( | |||||
| Ulp1 protease | n.i. | 40* | Jiang et al. ( | |||||
| ELK16 | 16 | β-sheet | PTPPTT PTPPTTPTPTP Unstructured | Amadoriase II | 120 | 88* | Wu et al. ( | |
| β-xylosidase | 94 | 77* | Wu et al. ( | |||||
| GFP | n.i. | n.a. | Wu et al. ( | |||||
| 18A (and variants) | 18 | α-helical | PTPPTT PTPPTTPTPTP Unstructured | Lipase A | 90 | 150* | Lin et al. ( | |
| Amadoriase II | n.i. | n.i. | Lin et al. ( | |||||
| β-xylosidase | n.i. | n.i. | Lin et al. ( | |||||
| GFP | n.i. | n.a. | Lin et al. ( | |||||
| II. Coiled coil domains | ||||||||
| TDoT ( | 53 | Tetrameric coiled coil | (GGGS)3 Unstructured | Hydroxynitrile lyase | 76 | 11 | Diener et al. ( | |
| MenD3 | 90 | n.i. | Diener et al. ( | |||||
| Lipase A | 114 | n.i. | Diener et al. ( | |||||
| Alcohol dehydrogenase | 88 | 2 | Jäger et al. ( | |||||
| Alcohol dehydrogenase | 5 | 6 | Jäger et al. ( | |||||
| Benzaldehyde lyase | 88 | 1 | Jäger et al. ( | |||||
| Benzoylformate decarboxylase | 1 | 4 | Jäger et al. ( | |||||
| Lysine decarboxylase | n.i. | n.i. | Jäger et al. ( | |||||
| YFP | 65 | n.a. | Jäger et al. ( | |||||
| mCherry | 42 | n.a. | Jäger et al. ( | |||||
| 3HAMP ( | 172 | Dimeric coiled coil | (GGGS)3 Unstructured | Alcohol dehydrogenase | 75 | 12 | Jäger et al. ( | |
| Alcohol dehydrogenase | 67 | 1 | Jäger et al. ( | |||||
| Benzaldehyde lyase | 76 | 18 | Jäger et al. ( | |||||
| Benzoylformate decarboxylase | 61 | 10 | Jäger et al. ( | |||||
| Lysine decarboxylase | n.i. | n.i. | Kloss et al. ( | |||||
| YFP | 6 | n.a. | Jäger et al. ( | |||||
| mCherry | 5 | n.a. | Jäger et al. ( | |||||
| Target (origin) | ||||||||
| III. Aggregation-prone proteins (protein domains) | ||||||||
| Aβ42(F19D) ( | 42 | n.i. | BFP | 61–65 | 314 | Garcia-Fruitos et al. ( | ||
| CBDcell ( | 108 | Cellulose-binding protein | n.i. | β-glucuronidase | 92 | 19 | Choi et al. ( | |
| β-glycosidase | 93 | n.i. | Choi et al. ( | |||||
| DsRed | n.i. | n.a. | Choi et al. ( | |||||
| CBDclos ( | 156 | Cellulose-binding protein | 43 amino acids with thrombin cleavage site, S-Tag™, and cloning site | > 90 | 42* | Nahalka and Nidetzky ( | ||
| 100 | 100* | Nahalka et al. ( | ||||||
| Maltodextrin phosphorylase | 83 | n.i. | Nahalka et al. ( | |||||
| Cytidylate kinase | n.i. | n.i. | Nahalka and Patoprsty ( | |||||
| Polyphosphate kinase PPK3 | n.i. | n.i. | Nahalka and Patoprsty ( | |||||
| GFP | n.i. | n.i. | Koszagova et al. ( | |||||
| GalU5 | n.i. | n.i. | Koszagova et al. ( | |||||
| VP1 capsid protein (foot-and-mouth disease virus) | 209 | Virus capsid protein | n.i. | β-galactosidase | 36-46 | 166* | Garcia-Fruitos et al. ( | |
| GFP | n.i. | n.a. | Garcia-Fruitos et al. ( | |||||
| GFP ( | 238 | Fluorescent protein | (GGGS)5 Flexible (AAAKE)5 Rigid | Acid phosphatase | n.i. n.i. | 48 58 | Huang et al. ( | |
| MalE31 ( | 396 | Maltose binding protein | RIPGG Unstructured | Alkaline phosphatase | > 95 | n.i. | Arie et al. ( | |
| β-lactamase | > 95 | n.i. | Arie et al. ( | |||||
| PoxB ( | 574 | Pyruvate oxidase | n.i. | GFP | n.i. | n.a. | Park et al. ( | |
| α-amylase | 77 | 2006 | Park et al. ( | |||||
Fig. 2Hydrophobic patch analysis of CatIB formation–inducing tags. All structures are shown in cartoon representation in gray with the Rosetta-identified hydrophobic surface patches shown as blue surfaces (Kuhlman and Baker 2000; Rohl et al. 2004). a Artificial peptides: L6KD, GFIL8, ELK16, and 18AWT. Structures were modelled with Yasara (Krieger and Vriend 2014, 2015) to depict their reported structure. Structures are shown in cartoon representation with residues as sticks. Carbon atoms in gray, nitrogen in blue, and oxygen in red. The amino acid sequence (in single-letter code) of each peptide tag is shown below each model, with non-polar residues in black and polar residues in red (anionic residues) and blue (cationic residues), respectively. b CatIB formation–inducing coiled coil domains: tetrameric TDoT and dimeric 3HAMP. c Aggregation-prone proteins reported to induce CatIB formation. As representative structure of Aβ42 (F19D), the structure of the wild-type Aβ42 monomer is shown (left side; circled with a dashed line) with all side chains in stick representation. F19, residing within the central hydrophobic cluster constituted by residues 17-21 (de Groot et al. 2006), is highlighted in red. In addition, the recently solved structure of the Aβ42 amyloid fibril (Gremer et al. 2017) is shown to illustrate the crossed β-pleated sheet packing of amyloids. For VP1, the foot-and-mouth disease virus (FMDV) capsid protein, the monomeric VP1 subunit (in cartoon representation; circled with a dashed line), as well as the structure of the 240-mer empty capsid constituted by VP1 (blue), VP2 (green), VP3 (red), and VP4 (yellow) of the FMDV A22 (Porta et al. 2013). PDB-IDs: TDoT: 1FE6; 3HAMP: 3LNR; Aβ1-42: 5OQV; VP1: 4IV1; GFP: 1GFL; MalE31: 1LAX; CBDcell: 1EXG. No structures are available for PoxB and CBDclos
Fig. 3Hydrophobic patch analysis of selected target proteins which were produced as CatIBs. a All target proteins from Table 1 for which a structure is known were analyzed for the presence of hydrophobic surface patches. All structures are shown in cartoon representation in gray with the Rosetta-identified hydrophobic surface patches shown as blue surfaces (Kuhlman and Baker 2000; Rohl et al. 2004) calculated as described in Jäger et al. (2019a). Proteins are identified by PDB-IDs (see below). b Correlation between CatIB formation efficiency and fraction of hydrophobic surface patches. Hydrophobic surface patches for the corresponding target protein structures were quantified by employing the hpatch tool of the Rosetta modelling suite (Kuhlman and Baker 2000; Rohl et al. 2004; Jacak et al. 2012). Surface areas were quantified using Pymol 1.7.0.0 (Schrödinger, LCC, New York, NY, USA). CatIB formation efficiency as the relative activity of the insoluble CatIB fraction (Table 1). Coefficient of determination values (R2) is given excluding (black) and including outliers (blue). Outliers are identified by PDB ID and are depicted with blue crosses. PDB-IDs are as follows: 2H5Q: mCherry, 1UA7: B. subtilis α-amylase, 5DEI: P. putida benzoylformate decarboxylase, 1ED9: E. coli alkaline phosphatase, 5ZQJ: B. pumilus β-xylosidase, 1BTL: E. coli β-lactamase, 1BGL: E. coli β-galactosidase, 1ZK4: L. brevis alcohol dehydrogenase, 1YFP: yellow fluorescent protein, 3DJD: A. fumigatus amadoriase II, 2JLC: E. coli MenD, 3LBM: E. colid-sialic acid aldolase, 1BFP: blue fluorescent protein, 3DQZ: A. thaliana hydroxynitrile lyase, 2UZI: P. fluorescens benzaldehyde lyase, 3K46: E. coli β-glucuronidase, 4BMN: Ralstonia sp. alcohol dehydrogenase, 1ISP: B. subtilis lipase A